Publication

Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia

Journal Paper/Review - Nov 27, 1999

Units
PubMed

Citation
Dickenmann M, Tamm M, Tsinalis D, Binet F, Thiel G, Steiger J. Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia. Transplantation 1999; 68:1606-8.
Type
Journal Paper/Review (English)
Journal
Transplantation 1999; 68
Publication Date
Nov 27, 1999
Issn Print
0041-1337
Pages
1606-8
Brief description/objective

BACKGROUND: Pneumocystis carinii pneumonia (PcP) in immunocompromised patients is suggested if the following symptoms develop: dyspnea, fever, and interstitial infiltrates on chest x-ray. We observed a significant blood eosinophilia in kidney recipients with PcP under immunosuppressive treatment with tacrolimus. METHODS: Blood eosinophil counts of kidney recipients under immunosuppression with tacrolimus suffering from PcP were compared to eosinophil counts of patients without evidence of PcP and to patients showing PcP under immunosuppression with cyclosporine. RESULTS: PcP-positive patients treated with tacrolimus showed a significantly higher blood eosinophil count compared to PcP-positive patients treated with cyclosporine (P=0.01), and to patients under immunosuppression with tacrolimus without PcP, respectively (P=0.006). Eosinophilia preceded the time of a definitive PcP diagnosis by bronchoalveolar lavage and decreased after successful treatment. CONCLUSIONS: An increasing blood eosinophil count can be an indicator of P. carinii pneumonia in patients under immunosuppressive therapy with tacrolimus.